GGrantIndex
← Leaderboards

Jonathan D Smith

Rockefeller University

$27,770,048
Attributed
$32,316,948
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$32,316,948 · 15

By mechanism

R01$18,190,205 · 6
P01$9,088,168 · 6
T32$2,636,217 · 2
P50$2,402,358 · 1

Top collaborators

Most similar at Rockefeller University

Same institution · by research overlap

Others in their field

Top investigators on “Atherosclerosis

Research focus

AtherosclerosisTissuesPathway InteractionsProteinsInsightCholesterolCellsLipidsMouse ModelGenetic VariantGeneticPredispositionMediatingGenesVariantLeadPreventLesionAreaHigh Density LipoproteinsPlayQuantitative Trait LociInflammationMacrophage

Grant awards (81)

Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology$507,150
P01 · FY2025 · HL · contact PI
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University$321,270
T32 · FY2025 · GM · contact PI
Genetic modifiers of atherosclerosis and macrophage phenotypes$573,299
R01 · FY2024 · HL · contact PI
Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology$497,006
P01 · FY2024 · HL · contact PI
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University$329,616
T32 · FY2024 · GM · contact PI
Genetic modifiers of atherosclerosis and macrophage phenotypes$618,808
R01 · FY2023 · HL · contact PI
Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology$507,150
P01 · FY2023 · HL · contact PI
ApoA1 lipidation by ABCA1 in HDL biogenesis$479,456
R01 · FY2023 · HL · contact PI
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University$318,321
T32 · FY2023 · GM · contact PI
Genetic modifiers of atherosclerosis and macrophage phenotypes$632,638
R01 · FY2022 · HL · contact PI
Project 1 - Genes to Function: Causal Genes and their Roles in Cardiomyocyte and Atrial Physiology$507,150
P01 · FY2022 · HL · contact PI
ApoA1 lipidation by ABCA1 in HDL biogenesis$479,456
R01 · FY2022 · HL · contact PI
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University$312,217
T32 · FY2022 · GM · contact PI
Genetic modifiers of atherosclerosis and macrophage phenotypes$632,638
R01 · FY2021 · HL · contact PI
ApoA1 lipidation by ABCA1 in HDL biogenesis$479,456
R01 · FY2021 · HL · contact PI
Molecular Medicine Training Program at Cleveland Clinic/Case Western Reserve University$292,577
T32 · FY2021 · GM · contact PI
ApoA1 lipidation by ABCA1 in HDL biogenesis$479,456
R01 · FY2020 · HL · contact PI
Molecular Medicine Training Program$137,345
T32 · FY2020 · GM · contact PI
Functional Genomics of Atrial Fibrillation$763,008
R01 · FY2019 · HL
Genetic Modifiers of atherosclerosis and foam cell lipid droplet metabolism-Proje$430,782
P01 · FY2019 · HL · contact PI
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis$396,250
R01 · FY2019 · HL · contact PI
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis$393,000
R01 · FY2019 · HL · contact PI
Molecular Medicine Training Program$190,645
T32 · FY2019 · GM · contact PI
Atherosclerosis and Lipoprotein Analysis Core C$122,201
P01 · FY2019 · HL · contact PI
Functional Genomics of Atrial Fibrillation$768,261
R01 · FY2018 · HL
Genetic Modifiers of atherosclerosis and foam cell lipid droplet metabolism-Proje$430,780
P01 · FY2018 · HL · contact PI
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis$396,250
R01 · FY2018 · HL · contact PI
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis$393,000
R01 · FY2018 · HL · contact PI
Molecular Medicine Training Program$188,520
T32 · FY2018 · GM · contact PI
Atherosclerosis and Lipoprotein Analysis Core C$122,204
P01 · FY2018 · HL · contact PI
Molecular Medicine Training Program$86,400
T32 · FY2018 · GM · contact PI
Functional Genomics of Atrial Fibrillation$779,471
R01 · FY2017 · HL
Genetic Modifiers of atherosclerosis and foam cell lipid droplet metabolism-Proje$430,782
P01 · FY2017 · HL · contact PI
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis$396,250
R01 · FY2017 · HL · contact PI
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis$393,000
R01 · FY2017 · HL · contact PI
Molecular Medicine Training Program$186,446
T32 · FY2017 · GM · contact PI
Atherosclerosis and Lipoprotein Analysis Core C$122,201
P01 · FY2017 · HL · contact PI
Functional Genomics of Atrial Fibrillation$788,782
R01 · FY2016 · HL
Genetic Modifiers of atherosclerosis and foam cell lipid droplet metabolism-Proje$430,779
P01 · FY2016 · HL · contact PI
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis$407,625
R01 · FY2016 · HL · contact PI
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis$396,250
R01 · FY2016 · HL · contact PI
Molecular Medicine Training Program$184,424
T32 · FY2016 · GM · contact PI
Atherosclerosis and Lipoprotein Analysis Core C$122,203
P01 · FY2016 · HL · contact PI
Functional Genomics of Atrial Fibrillation in Human Atria$800,640
R01 · FY2015 · HL
Genetic Modifiers of atherosclerosis and foam cell lipid droplet metabolism-Proje$430,782
P01 · FY2015 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core C$122,201
P01 · FY2015 · HL · contact PI
Molecular Medicine Training Program$88,436
T32 · FY2015 · GM · contact PI
Functional Genomics of Atrial Fibrillation in Human Atria$795,107
R01 · FY2014 · HL
ABCA1, ApoAI and Reverse Cholesterol Transport$499,301
P01 · FY2014 · HL · contact PI
Functional Genomics of Atrial Fibrillation in Human Atria$7,265
R01 · FY2014 · HL
Functional Genomics of Atrial Fibrillation in Human Atria$670,706
R01 · FY2013 · HL
ABCA1, ApoAI and Reverse Cholesterol Transport$485,034
P01 · FY2013 · HL · contact PI
Characterization of Atherosclerosis Modifier Genes$444,166
R01 · FY2013 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core$248,583
P01 · FY2013 · HL · contact PI
Functional Genomics of Atrial Fibrillation in Human Atria$689,294
R01 · FY2012 · HL
ABCA1, ApoAI and Reverse Cholesterol Transport$509,490
P01 · FY2012 · HL · contact PI
Characterization of Atherosclerosis Modifier Genes$466,560
R01 · FY2012 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core$261,118
P01 · FY2012 · HL · contact PI
ABCA1, ApoAI and Reverse Cholesterol Transport$506,385
P01 · FY2011 · HL · contact PI
Characterization of Atherosclerosis Modifier Genes$466,502
R01 · FY2011 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core$261,118
P01 · FY2011 · HL · contact PI
ABCA1, ApoAI and Reverse Cholesterol Transport$512,595
P01 · FY2010 · HL · contact PI
Characterization of Atherosclerosis Modifier Genes$465,718
R01 · FY2010 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core$108,228
P01 · FY2010 · HL · contact PI
Genetics of Atherosclerosis in a Murine Model$488,260
P50 · FY2009 · HL · contact PI
Atherosclerosis and Lipoprotein Analysis Core$108,228
P01 · FY2009 · HL · contact PI
Genetics of Atherosclerosis in a Murine Model$499,947
P50 · FY2008 · HL · contact PI
ABCA1, ApoAI, and Lipid Efflux$366,235
R01 · FY2008 · HL · contact PI
Genetics of Atherosclerosis in a Murine Model$485,383
P50 · FY2007 · HL · contact PI
ABCA1, ApoAI, and Lipid Efflux$366,235
R01 · FY2007 · HL · contact PI
Genetics of Atherosclerosis in a Murine Model$471,246
P50 · FY2006 · HL · contact PI
ABCA1, ApoAI, and Lipid Efflux$377,173
R01 · FY2006 · HL · contact PI
Genetics of Atherosclerosis in a Murine Model$457,522
P50 · FY2005 · HL
ABCA1, ApoAI, and Lipid Efflux$386,250
R01 · FY2005 · HL
Macrophage lipid efflux and atherosclerosis$306,000
R01 · FY2004 · HL
Macrophage lipid efflux and atherosclerosis$306,000
R01 · FY2003 · HL
Macrophage lipid efflux and atherosclerosis$296,000
R01 · FY2002 · HL
Macrophage lipid uptake, efflux, and atherosclerosis$268,239
P01 · FY2002 · HL
Macrophage lipid efflux and atherosclerosis$334,000
R01 · FY2001 · HL
Macrophage lipid uptake, efflux, and atherosclerosis$268,239
P01 · FY2001 · HL
Macrophage lipid uptake, efflux, and atherosclerosis$268,239
P01 · FY2000 · HL